SCHEMBL7009312

SCHEMBL7009312

CCCC1SC=CN1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21527442 0.55
Butane SCHEMBL27893070 0.51 TPMT (0.55)
Acetic Acid SCHEMBL11473957 0.50
Benzene SCHEMBL11654948 0.50 HDAC3 (0.56)
Butane SCHEMBL1329645 0.49 FFAR3 (0.54)
Butane SCHEMBL21633593 0.49 FFAR3 (0.54)
Butane SCHEMBL40275 0.49 FFAR3 (0.54)
Butane SCHEMBL29197512 0.49 FFAR3 (0.54)
Butane SCHEMBL28896048 0.49 FFAR3 (0.54)
Butane SCHEMBL1165212 0.49 FFAR3 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0690863-B1 TETRACYCLIC COMPOUNDS AS DOPAMINE AGONISTS ABBOTT LAB (US) 2003-03-05 EP disclosed
EP-0690863-A1 TETRACYCLIC COMPOUNDS AS DOPAMINE AGONISTS ABBOTT LABORATORIES (US) 1996-01-10 EP disclosed
EP-0690863-A4 TETRACYCLIC COMPOUNDS AS DOPAMINE AGONISTS ABBOTT LAB (US) 1995-11-07 EP disclosed
WO-1994022858-A1 TETRACYCLIC COMPOUNDS AS DOPAMINE AGONISTS ABBOTT LABORATORIES (US) 1994-10-13 WO disclosed